Dual time point 2-deoxy-2-[18F] fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.

被引:0
|
作者
Garcia Vicente, A. M. [1 ]
Palomar Munoz, A. [1 ]
Leon Martin, A. [2 ]
Ortega Ruiperez, C. [3 ]
Espinosa Aunion, R. [4 ]
Gonzalez Ageitos, A. [5 ]
Chacon Muniz, I. [6 ]
Sancho Calatrava, E. [7 ]
Pilkington Woll, P. [1 ]
Jimenez Londono, G. [1 ]
Nunez Garcia, A. [1 ]
Soriano Castrejon, A. [1 ]
机构
[1] Univ Gen Hosp, Dept Nucl Med, Ciudad Real, Spain
[2] Univ Gen Hosp, Invest Unit, Ciudad Real, Spain
[3] Virgen de la Luz Hosp, Dept Oncol, Cuenca, Spain
[4] La Mancha Ctr Hosp, Dept Oncol, Ciudad Real, Spain
[5] Nuestra Sra Prado, Dept Oncol, Talavera De La Reina, Toledo, Spain
[6] Virgen de la Salud Hosp, Dept Oncol, Toledo, Spain
[7] Santa Barbara Hosp, Dept Surg, Ciudad Real, Spain
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP702
引用
收藏
页码:S297 / S297
页数:1
相关论文
共 50 条
  • [1] Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: Nodal staging in locally advanced breast cancer
    Garcia Vicente, A. M.
    Soriano Castrejon, A.
    Cruz Mora, M. A.
    Ortega Ruiperez, C.
    Espinosa Aunion, R.
    Leon Martin, A.
    Gonzalez Ageitos, A.
    Van Gomez Lopez, O.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (01): : 1 - 5
  • [2] Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT
    Ghodsian, M
    Obrzut, SL
    Hyde, CC
    Watts, WJ
    Schiepers, C
    [J]. CLINICAL NUCLEAR MEDICINE, 2005, 30 (11) : 717 - 720
  • [3] Autoradiolysis of the 2-deoxy-2-[18F]fluoro-D-glucose radiopharmaceutical
    E. Búriová
    F. Macášek
    F. Melichar
    M. Kropáček
    L. Procházka
    [J]. Journal of Radioanalytical and Nuclear Chemistry, 2005, 264 : 595 - 602
  • [4] Autoradiolysis of the 2-deoxy-2-[18F]fluoro-D-glucose radiopharmaceutical
    Búriová, E
    Macásek, F
    Melichar, F
    Kropácek, M
    Procházka, L
    [J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2005, 264 (03) : 595 - 602
  • [5] Radiotherapeutic use of 2-deoxy-2-[18F]fluoro-D-glucose – a comment
    Michael Andrew Meyer
    [J]. Breast Cancer Research, 6
  • [6] Standardised uptake values of 2-deoxy-2-[18F]fluoro-D-glucose using PET/CT in normal cats
    Cho, Y. K.
    Lee, K. C.
    [J]. VETERINARNI MEDICINA, 2013, 58 (02) : 96 - 104
  • [7] A prospective evaluation of the utility of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer
    Smyth, Elizabeth
    Schoeder, Heiko
    Strong, Vivian E.
    Capanu, Marinela
    Kelsen, David P.
    Coit, Daniel G.
    Shah, Manish A.
    [J]. CANCER, 2012, 118 (22) : 5481 - 5488
  • [8] Lymphoma: Role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging
    Moog, F
    Bangerter, M
    Diederichs, CG
    Guhlmann, A
    Kotzerke, J
    Merkle, E
    Kolokythas, O
    Herrmann, F
    Reske, SN
    [J]. RADIOLOGY, 1997, 203 (03) : 795 - 800
  • [9] In Vitro 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake: Practical Considerations
    Mertens, Koen
    Mees, Gilles
    Lambert, Bieke
    Van de Wiele, Christophe
    Goethals, Ingeborg
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (03) : 183 - 188
  • [10] 2-deoxy-2-[18F]fluoro-D-glucose uptake and correlation to intratumoral heterogeneity
    Henriksson, Eva
    Kjellen, Elisabeth
    Wahlberg, Peter
    Ohlsson, Tomas
    Wennerberg, Johan
    Brun, Eva
    [J]. ANTICANCER RESEARCH, 2007, 27 (4B) : 2155 - 2159